Market Closed -
Nasdaq
04:00:00 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
12.73
USD
|
+2.33%
|
|
-4.29%
|
+9.93%
|
Fiscal Period: Juni |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,285
|
1,063
|
1,170
|
774.8
|
554.9
|
515.6
|
-
|
-
|
Enterprise Value (EV)
1 |
1,530
|
1,358
|
1,170
|
1,117
|
948.5
|
816.7
|
812.4
|
786.5
|
P/E ratio
|
23.5
x
|
31.7
x
|
21.6
x
|
15.8
x
|
16.9
x
|
34.4
x
|
17.9
x
|
14.5
x
|
Yield
|
1.45%
|
1.83%
|
1.66%
|
2.51%
|
3.5%
|
3.77%
|
3.72%
|
3.69%
|
Capitalization / Revenue
|
1.55
x
|
1.33
x
|
1.4
x
|
0.82
x
|
0.57
x
|
0.52
x
|
0.5
x
|
0.49
x
|
EV / Revenue
|
1.85
x
|
1.7
x
|
1.4
x
|
1.18
x
|
0.97
x
|
0.82
x
|
0.79
x
|
0.74
x
|
EV / EBITDA
|
13
x
|
13.3
x
|
10.8
x
|
10.1
x
|
8.41
x
|
6.94
x
|
6.52
x
|
6.4
x
|
EV / FCF
|
17.4
x
|
20
x
|
14.9
x
|
-
|
-
|
22.3
x
|
49.5
x
|
37.3
x
|
FCF Yield
|
5.76%
|
5%
|
6.72%
|
-
|
-
|
4.49%
|
2.02%
|
2.68%
|
Price to Book
|
5.95
x
|
5.65
x
|
-
|
2.95
x
|
1.96
x
|
1.82
x
|
1.7
x
|
1.57
x
|
Nbr of stocks (in thousands)
|
40,454
|
40,454
|
40,504
|
40,504
|
40,504
|
40,504
|
-
|
-
|
Reference price
2 |
31.77
|
26.27
|
28.88
|
19.13
|
13.70
|
12.73
|
12.73
|
12.73
|
Announcement Date
|
8/27/19
|
8/26/20
|
8/25/21
|
8/24/22
|
8/30/23
|
-
|
-
|
-
|
Fiscal Period: Juni |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
828
|
800.4
|
833.4
|
942.3
|
977.9
|
997.7
|
1,029
|
1,062
|
EBITDA
1 |
118
|
102.1
|
107.9
|
111.1
|
112.8
|
117.7
|
124.5
|
123
|
EBIT
1 |
96.6
|
78.7
|
84.7
|
87.3
|
88.4
|
81.44
|
87.61
|
98.57
|
Operating Margin
|
11.67%
|
9.83%
|
10.16%
|
9.26%
|
9.04%
|
8.16%
|
8.52%
|
9.28%
|
Earnings before Tax (EBT)
1 |
71.5
|
55.51
|
66.5
|
-
|
54.1
|
23
|
39
|
51
|
Net income
1 |
54.7
|
33.55
|
54.4
|
49.18
|
32.6
|
15.16
|
28.8
|
35.8
|
Net margin
|
6.61%
|
4.19%
|
6.53%
|
5.22%
|
3.33%
|
1.52%
|
2.8%
|
3.37%
|
EPS
2 |
1.350
|
0.8300
|
1.340
|
1.210
|
0.8100
|
0.3700
|
0.7100
|
0.8800
|
Free Cash Flow
1 |
88.11
|
67.96
|
78.56
|
-
|
-
|
36.7
|
16.4
|
21.1
|
FCF margin
|
10.64%
|
8.49%
|
9.43%
|
-
|
-
|
3.68%
|
1.59%
|
1.99%
|
FCF Conversion (EBITDA)
|
74.67%
|
66.53%
|
72.81%
|
-
|
-
|
31.18%
|
13.17%
|
17.16%
|
FCF Conversion (Net income)
|
161.08%
|
202.54%
|
144.42%
|
-
|
-
|
242.14%
|
56.95%
|
58.94%
|
Dividend per Share
2 |
0.4600
|
0.4800
|
0.4800
|
0.4800
|
0.4800
|
0.4800
|
0.4733
|
0.4700
|
Announcement Date
|
8/27/19
|
8/26/20
|
8/25/21
|
8/24/22
|
8/30/23
|
-
|
-
|
-
|
Fiscal Period: June |
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
214.7
|
232.7
|
239.6
|
255.3
|
232.5
|
244.6
|
245.7
|
255
|
231.3
|
249.9
|
253.6
|
265.1
|
EBITDA
1 |
22.5
|
29.1
|
28
|
31.53
|
22.13
|
30.9
|
27.4
|
32.3
|
18.7
|
29.5
|
37.68
|
40.43
|
EBIT
1 |
16.8
|
23.3
|
21.8
|
25.5
|
16.1
|
24.8
|
21.3
|
26.2
|
12.2
|
23
|
21.56
|
24.31
|
Operating Margin
|
7.82%
|
10.01%
|
9.1%
|
9.99%
|
6.92%
|
10.14%
|
8.67%
|
10.27%
|
5.27%
|
9.2%
|
8.5%
|
9.17%
|
Earnings before Tax (EBT)
|
9.6
|
-
|
-
|
-
|
-
|
12.1
|
15.1
|
21.4
|
-12
|
-
|
-
|
-
|
Net income
1 |
6.5
|
17.5
|
17.69
|
7.487
|
3.9
|
7.2
|
10
|
11.5
|
-8
|
1.3
|
9.849
|
12.01
|
Net margin
|
3.03%
|
7.52%
|
7.38%
|
2.93%
|
1.68%
|
2.94%
|
4.07%
|
4.51%
|
-3.46%
|
0.52%
|
3.88%
|
4.53%
|
EPS
2 |
0.1600
|
0.4300
|
0.4400
|
0.1800
|
0.1000
|
0.1800
|
0.2500
|
0.2800
|
-0.2000
|
0.0300
|
0.2400
|
0.3000
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
0.1200
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/2/21
|
2/9/22
|
5/4/22
|
8/24/22
|
11/9/22
|
2/8/23
|
5/3/23
|
8/30/23
|
11/8/23
|
2/7/24
|
-
|
-
|
Fiscal Period: June |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
245
|
296
|
-
|
342
|
394
|
301
|
297
|
271
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.073
x
|
2.895
x
|
-
|
3.076
x
|
3.489
x
|
2.559
x
|
2.384
x
|
2.203
x
|
Free Cash Flow
1 |
88.1
|
68
|
78.6
|
-
|
-
|
36.7
|
16.4
|
21.1
|
ROE (net income / shareholders' equity)
|
27.3%
|
21.7%
|
25.5%
|
19.6%
|
18%
|
17.3%
|
16.2%
|
16.9%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
5.340
|
4.650
|
-
|
6.480
|
6.980
|
7.010
|
7.480
|
8.100
|
Cash Flow per Share
2 |
1.160
|
1.470
|
1.930
|
1.880
|
-
|
1.100
|
1.250
|
1.740
|
Capex
1 |
29.9
|
34
|
29.3
|
-
|
-
|
41.6
|
40.3
|
42.1
|
Capex / Sales
|
3.61%
|
4.25%
|
3.52%
|
-
|
-
|
4.17%
|
3.92%
|
3.96%
|
Announcement Date
|
8/27/19
|
8/26/20
|
8/25/21
|
8/24/22
|
8/30/23
|
-
|
-
|
-
|
Mean consensus UNDERPERFORM Last Close Price
12.73
USD Average target price
10.75
USD Spread / Average Target -15.55% Consensus |
1st Jan change
|
Capi.
|
---|
| +9.93% | 516M | | -19.73% | 72.39B | | -11.01% | 6.54B | | +15.88% | 3.43B | | -2.92% | 3.12B | | -0.68% | 1.4B | | -17.27% | 1.34B | | -2.73% | 1.26B | | -14.67% | 1.12B | | -5.37% | 990M |
Veterinary Drugs
|